title: Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Conzo
authors.forename: Luisa
authors.initials: L
authors.lastname: Circelli
authors.forename: Daniela
authors.initials: D
authors.lastname: Pasquali
authors.forename: Antonio
authors.initials: A
authors.lastname: Sinisi
authors.forename: Lina
authors.initials: L
authors.lastname: Sabatino
authors.forename: Giacomo
authors.initials: G
authors.lastname: Accardo
authors.forename: Andrea
authors.initials: A
authors.lastname: Renzullo
authors.forename: Luigi
authors.initials: L
authors.lastname: Santini
authors.forename: Francesco
authors.initials: F
authors.lastname: Salvatore
authors.forename: Vittorio
authors.initials: V
authors.lastname: Colantuoni
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D018813:Multiple Endocrine Neoplasia Type 2a / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D009154:Mutation; D000090063:Proto-Oncogene Mas; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics*
chemical_list: C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human